Hartmanis held leadership positions in Gambro, Amersham and Pharmacia and was appointed as CEO of the specialty pharmaceutical company BioPhausia in 2010.
Medivir chairman of the board Goran Pettersson said through the appointment of Maris Hartmanis as CEO, they secure an appropriate succession of the leadership of Medivir and a continued positive development of Medivir as a research-based specialty pharmaceutical company.